Status | Study |
RECRUITING |
Study Name: Evaluate REC-4881 in Patients With FAP Condition: Familial Adenomatous Polyposis Date: 2022-09-14 Interventions: REC-4881 4mg capsules |
RECRUITING |
Study Name: Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis Condition: Familial Adenomatous Polyposis Date: 2019-01-09 Interventions: 500mg capsule, two 500mg capsules to be taken twice daily for 24 months |
Recruiting |
Study Name: Sirolimus and Familial Adenomatous Polyposis (FAP) Condition: Adenomatous Polyposis Coli Date: 2017-03-21 Interventions: Drug: Sirolimus Participants will be given sirolimus tablets. The starting dose is 2 mg once daily which |
Not yet recruiting |
Study Name: Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis. Condition: Familial Adenomatous Polyposis FAP Date: 2017-02-14 Interventions: Dietary Supplement: Wholistic Turmeric capsules |
Not yet recruiting |
Study Name: Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer Condition: Attenuated Familial Adenomatous Polyposis Date: 2016-11-10 Interventions: Drug: Erlotinib Hydrochloride |
Recruiting |
Study Name: Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program Condition: Attenuated Familial Adenomatous Polyposis Deleterious Date: 2016-04-14 Interventions: Other: Chart Review Database queried for the presence of c |
Recruiting |
Study Name: Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP) Condition: Familial Adenomatous Polyposis Date: 2016-01-02 Interventions: Procedure: Duodenoscopy and enteroscopy |
Not yet recruiting |
Study Name: Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version Condition: FAP-Familial Adenomatous Polyposis Date: 2015-01-21 Interventions: Drug: Erythromycin Oral Treatment with Erythromycin 250-500mg, twice daily, for 16 weeks.Exact dose is s |
Completed |
Study Name: Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW Condition: Adenomatous Polyposis Coli Date: 2014-04-02 Interventions: Drug: Bevacizumab-IRDye800CW I |
Active, not recruiting |
Study Name: Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis Condition: FAP-Familial Adenomatous Polyposis Date: 2012-11-26 Interventions: Drug: Erythromycin Oral Treatment with Erythromycin 500mg, twice daily, for 12 weeks |